This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Olipass Corporation. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Daram Jung: Innovator in Antisense Oligonucleotide Technology
Introduction
Daram Jung is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antisense oligonucleotides. With a total of three patents to his name, Jung's work focuses on innovative solutions for medical conditions related to gene expression.
Latest Patents
One of Daram Jung's latest patents is for HIF 1-alpha antisense oligonucleotides. This invention provides peptide nucleic acid derivatives that target a specific part of the human HIF-1α pre-mRNA. These derivatives effectively induce exon skipping, resulting in splice variants of HIF-1α mRNA in cells. This technology holds promise for treating conditions associated with the overexpression of HIF-1α. Another notable patent is for SNAP25 antisense oligonucleotides, which also involves peptide nucleic acid derivatives. These derivatives target a 3' splice site of the human SNAP25 pre-mRNA and induce splice variants of the human SNAP25 mRNA in cells. This invention is particularly useful for safely treating dermatological conditions related to the expression of the human SNAP25 protein through topical administration.
Career Highlights
Daram Jung is currently associated with Olipass Corporation, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of antisense technology, contributing to innovative therapeutic approaches.
Collaborations
Throughout his career, Daram Jung has collaborated with notable colleagues, including Bongjun Cho and Kangwon Jang. These collaborations have further enhanced the impact of his research and innovations in biotechnology.
Conclusion
Daram Jung's contributions to the field of antisense oligonucleotide technology demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a leading inventor in biotechnology.